[
  {
    "ts": null,
    "headline": "Why Bristol-Myers Squibb Company (BMY) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom",
    "summary": "We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best pharma stocks to invest in now amid the domestic manufacturing boom. Trump Incentivizes Pharmaceuticals to Build Domestic Manufacturing […]",
    "url": "https://finnhub.io/api/news?id=7cd39b6540af98cada2c1252c74f28da92d927611e2bcbfef724c7eceb5f3d8d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747170305,
      "headline": "Why Bristol-Myers Squibb Company (BMY) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom",
      "id": 134461108,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best pharma stocks to invest in now amid the domestic manufacturing boom. Trump Incentivizes Pharmaceuticals to Build Domestic Manufacturing […]",
      "url": "https://finnhub.io/api/news?id=7cd39b6540af98cada2c1252c74f28da92d927611e2bcbfef724c7eceb5f3d8d"
    }
  },
  {
    "ts": null,
    "headline": "Big Pharma Counted on This Loophole. It May Be Closing.",
    "summary": "Big Pharma Counted on This Loophole. It May Be Closing.",
    "url": "https://finnhub.io/api/news?id=00363408f3372c83ebe1905f43bf95890be3b06d1c40df5f3fa24371493194b8",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747155180,
      "headline": "Big Pharma Counted on This Loophole. It May Be Closing.",
      "id": 134437979,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Big Pharma Counted on This Loophole. It May Be Closing.",
      "url": "https://finnhub.io/api/news?id=00363408f3372c83ebe1905f43bf95890be3b06d1c40df5f3fa24371493194b8"
    }
  },
  {
    "ts": null,
    "headline": "Big Pharma Counted On a Price Negotiation Loophole. It May Be Closing.",
    "summary": "Big Pharma Counted On a Price Negotiation Loophole. It May Be Closing.",
    "url": "https://finnhub.io/api/news?id=7d35b85b2f05094f233b38a4171fa62cde8e4585f5b0e055c8c75b9373ac287c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747144500,
      "headline": "Big Pharma Counted On a Price Negotiation Loophole. It May Be Closing.",
      "id": 134403148,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Big Pharma Counted On a Price Negotiation Loophole. It May Be Closing.",
      "url": "https://finnhub.io/api/news?id=7d35b85b2f05094f233b38a4171fa62cde8e4585f5b0e055c8c75b9373ac287c"
    }
  },
  {
    "ts": null,
    "headline": "Top Biotech Halozyme Undercuts Its Breakout On Bad Medicare News",
    "summary": "Halozyme Therapeutics shares tumbled Tuesday on a new Medicare approach to price negotiations for drugs that use additive products.",
    "url": "https://finnhub.io/api/news?id=f147396558cb3b63b8758c61c9ddb73e2f08f172b77971c94e101f005a4cd0ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747145994,
      "headline": "Top Biotech Halozyme Undercuts Its Breakout On Bad Medicare News",
      "id": 134408547,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Halozyme Therapeutics shares tumbled Tuesday on a new Medicare approach to price negotiations for drugs that use additive products.",
      "url": "https://finnhub.io/api/news?id=f147396558cb3b63b8758c61c9ddb73e2f08f172b77971c94e101f005a4cd0ce"
    }
  },
  {
    "ts": null,
    "headline": "Cytokinetics' heart disease drug shows improvement over standard of care in study",
    "summary": "Cytokinetics said on Tuesdayits experimental heart disease drug significantly improvedpatients' ability to exercise compared to standard-of-caretreatment in a late-stage study, sending shares of...",
    "url": "https://finnhub.io/api/news?id=1ca5fef40e5608a89987c839195114a490ddec6b2e5af9991ecfc226ffb77ffd",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747127832,
      "headline": "Cytokinetics' heart disease drug shows improvement over standard of care in study",
      "id": 134399220,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "Cytokinetics said on Tuesdayits experimental heart disease drug significantly improvedpatients' ability to exercise compared to standard-of-caretreatment in a late-stage study, sending shares of...",
      "url": "https://finnhub.io/api/news?id=1ca5fef40e5608a89987c839195114a490ddec6b2e5af9991ecfc226ffb77ffd"
    }
  },
  {
    "ts": null,
    "headline": "Cytokinetics' heart disease drug improves patients' ability to exercise",
    "summary": "Cytokinetics said on Tuesdayits experimental heart disease drug significantly improvedpatients' ability to exercise compared to standard-of-caretreatment in a late-stage study. The...",
    "url": "https://finnhub.io/api/news?id=0b7c99fc70394b6c2dfe4cb7b269871bad534e0ab2d30160890a3fa7edf10035",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747124897,
      "headline": "Cytokinetics' heart disease drug improves patients' ability to exercise",
      "id": 134398826,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "Cytokinetics said on Tuesdayits experimental heart disease drug significantly improvedpatients' ability to exercise compared to standard-of-caretreatment in a late-stage study. The...",
      "url": "https://finnhub.io/api/news?id=0b7c99fc70394b6c2dfe4cb7b269871bad534e0ab2d30160890a3fa7edf10035"
    }
  },
  {
    "ts": null,
    "headline": "Income Alert: 2 Bargain Blue Chips, Up To 8% Yield",
    "summary": "Bristol Myers Squibb (BMY) and MPLX present compelling value picks, offering high-income potential and attractive valuations in an overvalued market. See more.",
    "url": "https://finnhub.io/api/news?id=5ee4f0a8afc8990be39ac085787184da0c067c77f3a5e54635c6890580932711",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747123200,
      "headline": "Income Alert: 2 Bargain Blue Chips, Up To 8% Yield",
      "id": 134398707,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/476981829/image_476981829.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Bristol Myers Squibb (BMY) and MPLX present compelling value picks, offering high-income potential and attractive valuations in an overvalued market. See more.",
      "url": "https://finnhub.io/api/news?id=5ee4f0a8afc8990be39ac085787184da0c067c77f3a5e54635c6890580932711"
    }
  },
  {
    "ts": null,
    "headline": "One estimate of the profit hit from Trump's executive order on drug pricing",
    "summary": "One estimate of the profit hit from Trump's executive order on drug pricing",
    "url": "https://finnhub.io/api/news?id=31002be2202364c7d16f7dfe775830252e465b3bbd369109954fadbb022e5276",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747117031,
      "headline": "One estimate of the profit hit from Trump's executive order on drug pricing",
      "id": 134403150,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "One estimate of the profit hit from Trump's executive order on drug pricing",
      "url": "https://finnhub.io/api/news?id=31002be2202364c7d16f7dfe775830252e465b3bbd369109954fadbb022e5276"
    }
  }
]